How Will GLP-1s Change Restaurant Menus?

2 Min Read By MRM Staff

The increased use of glucagon-like peptide-1 (GLP-1) medications such as Ozempic and Wegovy is providing  profit opportunities for restaurants and other industries, according to Circana's The Ripple Effect of GLP-1s, Today and In the Future. The report revealed how users exhibit shifting purchasing habits over time, with weight-loss users making fewer food and beverage purchases during the first three months of use, and returning closer to benchmark levels by the end of the first year of use.

There is an opportunity for restaurant operators who want to embrace the GLP-1 movement by focusing on portion sizes and crafting "GLP-1-friendly”menu items, Sally Lyons Wyatt, global executive vice president and chief advisor, Circana, told Modern Restaurant Management (MRM) magazine. 

"By doing so, they can attract and foster repeat purchases from consumers are who either on GLP-1 medications or taking GLP-1 supplements," she said. "This could lead to increased traffic for the…